Short Interest in 3SBio Inc. (OTCMKTS:TRSBF) Drops By 17.3%

3SBio Inc. (OTCMKTS:TRSBF) was the target of a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 315,600 shares, a decline of 17.3% from the March 31st total of 381,800 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

3SBio Stock Performance

Shares of TRSBF remained flat at $0.80 during mid-day trading on Monday. The firm has a 50-day moving average of $0.80 and a two-hundred day moving average of $0.80. 3SBio has a 52 week low of $0.80 and a 52 week high of $0.80.

About 3SBio

3SBio Inc, an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of HER2-positive metastatic breast cancer in combination with chemotherapy; Interferon, a human interferon a2a for injection; and Inleusin, for the treatment of renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer and tuberculosis.